Business Context and Reporting Period
Company: Chicago Mercantile Exchange Holdings Inc. (CME Holdings)
Filing Type: Form 8-K (Current Report)
Date of Report: October 17, 2006
Event: Entry into a definitive Agreement and Plan of Merger with CBOT Holdings, Inc. and the Board of Trade of the City of Chicago, Inc. (CBOT).
Key Financial Metrics
This filing is a current report regarding a material definitive agreement and does not contain periodic financial statements (e.g., revenue, profit, cash flow, or debt levels). The only specific financial figures disclosed relate to the transaction terms:
- Exchange Ratio: 0.3006 shares of CME Holdings Class A common stock for each outstanding share of CBOT Holdings Class A common stock.
- Cash Consideration Cap: $3.0 billion aggregate limit for cash elections by CBOT stockholders.
- Termination Fee: $240.0 million payable by either party under specific termination circumstances.
Material Changes
The primary material change is the proposed merger of CBOT Holdings into CME Holdings. Upon closing:
- CBOT Holdings will cease to exist as a separate public entity, with CME Holdings continuing as the surviving company.
- The CBOT will become a subsidiary of CME Holdings.
- CBOT Holdings options will be converted into CME Holdings options adjusted for the exchange ratio.
Guidance, Outlook, and Risks
Transaction Conditions: The merger is subject to several closing conditions, including:
- Approval by stockholders of both CBOT Holdings and CME Holdings.
- Approval by Series B-1 and Series B-2 members of the CBOT regarding repurchase of Class B stock and charter amendments.
- Effectiveness of a Form S-4 registration statement.
- Receipt of necessary regulatory approvals.
Risks and Contingencies: The agreement includes customary termination rights. If terminated under certain circumstances, a $240.0 million termination fee is triggered. The filing explicitly states that representations and warranties are qualified by confidential disclosure schedules and should not be relied upon as characterizations of actual facts.
Outlook: The parties intend to file a joint proxy statement/prospectus with the SEC, which will contain detailed information regarding the transaction. No financial guidance or management commentary on future operating performance is provided in this document.
Investor Verification Checklist
- Verify the final approval status of the merger by stockholders of both CME Holdings and CBOT Holdings.
- Monitor the filing and contents of the joint proxy statement/prospectus (Form S-4) for detailed financial data and risk factors.
- Confirm receipt of all required regulatory approvals for the transaction to close.
- Review the specific terms of the cash election cap ($3.0 billion) and proration mechanics if cash elections exceed the limit.